The parathyroid calcium receptor: A novel therapeutic target for treating hyperparathyroidism

Pediatric Nephrology

Volumn 10, Issue 3, 1996, Pages 275-279

  Nemeth, Edward F ^a   Steffey, Michael E ^a   Fox, John ^a  

^a NPS Pharmaceutical Inc   (United States)

Author keywords

Calcimimetic hyperparathyroidism; Calcitonin; Calcium; Calcium receptor; End stage renal disease; Parathyroid hormone

Indexed keywords

CALCITONIN; CALCIUM ION; CELL SURFACE RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; METABOTROPIC RECEPTOR; N [3 (2 CHLOROPHENYL)PROPYL] 1 (3 METHOXYPHENYL)ETHYLAMINE; PARATHYROID HORMONE; RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; CALCITONIN BLOOD LEVEL; CALCIUM HOMEOSTASIS; CONFERENCE PAPER; DOSE RESPONSE; EXTRACELLULAR CALCIUM; HUMAN; HUMAN EXPERIMENT; NONHUMAN; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PARATHYROID CELL; PARATHYROID GLAND; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID HORMONE RELEASE; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; PROTEIN FAMILY; RAT; SECONDARY HYPERPARATHYROIDISM; SEQUENCE HOMOLOGY;

EID: 0029982638     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00866757     Document Type: Conference Paper

References (30)

1. Heath H III (1991) Primary hyperparathyroidism: recent advances in pathogenesis, diagnosis, and management. Adv Intern Med 37: 275-293
2. Coburn JW, Salusky IB (1994) Hyperparathyroidism in renal failure. Clinical features, diagnosis, and management. In: Bilezikian JP, Levine MA, Marcus R, (eds) The parathyroids. Raven, New York, pp 519-529
3. 2+-sensing receptor from bovine parathyroid. Nature 366: 575-580
4. 2+ and the regulation of secretion in parathyroid cells. FEBS Lett 203: 15-19
5. Garrett JE, Capuano IV, Hammerland LG, Hung BCP, Brown EM, Hebert SC, Nemeth EF, Fuller F (1995) Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs. J Biol Chem 270: 12919-12915
6. Riccardi D, Park J, Lee W-S, Gamba G, Brown EM, Hebert SC (1995) Cloning and functional expression of a rat kidney extracellular calcium/polyvalent cation-sensing receptor. Proc Natl Acad Sci USA 92: 131-135
7. Chen CJ, Barnett JV, Congo DA, Brown EM (1989) Divalent cations suppress 3′,5′-adenosine monophosphate accumulation by stimulating a pertussis toxin-sensitive guanine nucleotide-binding protein in cultured bovine parathyroid cells. Endocrinology 124: 233-239
8. 2+ stimulate accumulation of inositol phosphates in bovine parathyroid cells. FEBS Lett 218: 113-118
9. 2+ in bovine parathyroid cells evoked by extracellular divalent cations. Evidence for a cell surface calcium receptor. J Biol Chem 262: 5188-5196
10. 2+ and other ions as extracellular (first) messengers. Physiol Rev 71: 371-411
11. 2+ receptor-dependent regulation of cellular functions. News in Physiol Sci 10: 1-5
12. 2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75: 1297-1303
13. Khosla S, Ebeling PR, Firek AF, Burritt MM, Kao PC, Heath H III (1993) Calcium infusion suggests a "set-point" abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperparathyroidism. J Clin Endocrinol Metab 76: 715-720
14. Steffey ME, Fox J, Van Wagenen BC, DelMar EG, Balandrin MF, Nemeth EF (1993) Calcimimetics: structurally and mechanistically novel compounds that inhibit hormone secretion from parathyroid cells. J Bone Miner Res 8: S175
15. 2+ in parathyroid cells. In: Norman AW, Vanaman TC, Means AR (eds) Calcium-binding proteins in health and disease. Academic Press, New York, pp 33-35
16. Brown EM, Katz C, Butters R, Kifor O (1991) Neomycin mimics the effects of high extracellular calcium concentrations on parathyroid function in dispersed bovine parathyroid cells. Endocrinology 128: 3047-3054
17. Fox J, Hadfield S, Petty BA, Nemeth EF (1993) A first generation calcimimetic compound (NPS R-568) that acts on the parathyroid cell calcium receptor: a novel therapeutic approach for hyperparathyroidism. J Bone Miner Res 8: S181
18. Garrett JE, Tamir H, Kifor O, Simin RT, Rogers KV, Mithal A, Gagel RF, Brown EM (1995) Calcitonin-secreting cells of the thyroid express an extracellular calcium receptor gene. Endocrinology 136: 5202-5211
19. Fox J, Hadfield S, Petty BA, Conklin RL, Nemeth EF (1993) NPS R-568 acts on calcium receptors to inhibit parathyroid hormone and stimulate calcitonm secretion: a novel therapeutic approach for hyperparathyroidism. J Am Soc Nephrol 4: 719
20. Nemeth EF (1990) Regulation of cytosolic calcium by extracellular divalent cations in C-cells and parathyroid cells. Cell Calcium 11:323-327
21. Fox J, Conklin RL, Hadfield S, Petty BA, Nemeth EF (1994) Prevention of hypocalcemia prolongs the plasma parathyroid hormone and calcitonin responses to the calcimimetic compound NFS R-568 in rats. J Bone Miner Res 9: S409
22. Heath H III, Sanguinetti EL, Oglesby S, Marriott TB (1995) Inhibition of human parathyroid hormone secretion in vivo by NPS R-568, a calcimimetic drug that targets the parathyroid cell-surface calcium receptor. Bone 16: 85S
23. Slatopolsky E, Delmez JA (1994) Pathogenesis of secondary hyperparathyroidism. Am J Kidney Dis 23: 229-236
24. Fournier A, Drüeke T, Morinière P, Zingraff J, Boudailliez B, Achard JM (1992) The new treatments of hyperparathyroidism secondary to renal insufficiency. Adv Nephrol 21: 237-306
25. Fox J, Hadfield S, Petty BA, Conklin RL, Nemeth EF (1993) NPS R-568 inhibits parathyroid hormone secretion and stimulates calcitonin secretion in hyperparathyroid rats with chronic renal failure. J Am Soc Nephrol 4: 719
26. Ardaillou R, Sizonenko P, Meyrier A, Vallée G, Beaugas C (1970) Metabolic clearance rate of radioiodinated human calcitonin in man. J Clin Invest 49: 2345-2352
27. Fox J, Miller MA, Conklin RL, Lowe SH, Petty BA, Nemeth EF (1995) The calcimimetic NPS R-568 prevents the development of secondary hyperparathyroidism and elevated bone formation in rats with mild chronic renal insufficiency. J Bone Miner Res 10: S191
28. 2+-receptor expression in parathyroid adenomas and uremic hyperparathyroidism. J Bone Miner Res 10: S384
29. Quarles LD, Yohay DA, Carroll BA, Spritzer CE, Minda SA, Bartholomay D, Lobaugh BA (1994) Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD. Kidney Int 45: 1710-1721
30. Sherrard DJ, Hercz G, Pei Y, Maloney NA, Greenwood C, Manuel A, Saiphoo C, Fenton SS, Segre GV (1993) The spectrum of bone disease in end-stage renal failure - an evolving disorder. Kidney Int 43: 436-442